• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Current treatment for anorexia nervosa: efficacy, safety, and adherence.目前针对神经性厌食症的治疗:疗效、安全性和依从性。
Psychol Res Behav Manag. 2010;3:91-108. doi: 10.2147/PRBM.S13814. Epub 2010 Oct 19.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Comparative efficacy and acceptability of psychological interventions for the treatment of adult outpatients with anorexia nervosa: a systematic review and network meta-analysis.心理干预治疗成人门诊神经性厌食症的疗效和可接受性比较:系统评价和网络荟萃分析。
Lancet Psychiatry. 2021 Mar;8(3):215-224. doi: 10.1016/S2215-0366(20)30566-6. Epub 2021 Feb 15.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Psychotherapy for bulimia nervosa and binging.神经性贪食症和暴饮暴食的心理治疗
Cochrane Database Syst Rev. 2003(1):CD000562. doi: 10.1002/14651858.CD000562.
6
Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa.神经性厌食症和神经性贪食症的治疗进展。
CNS Drugs. 1994 Mar;1(3):201-12. doi: 10.2165/00023210-199401030-00005.
7
Current and emerging directions in the treatment of eating disorders.饮食失调治疗的当前及新出现的方向。
Subst Abuse. 2012;6:33-61. doi: 10.4137/SART.S7864. Epub 2012 Mar 29.
8
Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.成人神经性厌食症门诊治疗中的个体心理治疗。
Cochrane Database Syst Rev. 2015 Jul 27;2015(7):CD003909. doi: 10.1002/14651858.CD003909.pub2.
9
Update on the treatment of anorexia nervosa: review of clinical trials, practice guidelines and emerging interventions.神经性厌食症治疗的最新进展:临床试验、实践指南和新兴干预措施的综述。
Psychol Med. 2013 Dec;43(12):2477-500. doi: 10.1017/S0033291712002620. Epub 2012 Dec 10.
10
The MOSAIC study - comparison of the Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA) with Specialist Supportive Clinical Management (SSCM) in outpatients with anorexia nervosa or eating disorder not otherwise specified, anorexia nervosa type: study protocol for a randomized controlled trial.MOSAIC 研究 - 比较 Maudsley 成人神经性厌食症治疗模式(MANTRA)与专科支持性临床管理(SSCM)对神经性厌食症或其他特定类型未特指的进食障碍门诊患者的疗效:一项随机对照试验研究方案。
Trials. 2013 May 30;14:160. doi: 10.1186/1745-6215-14-160.

引用本文的文献

1
Motivation-Enhancing Psychotherapy for Inpatients With Anorexia Nervosa (MANNA): A Randomized Controlled Pilot Study.神经性厌食症住院患者的动机增强心理治疗(MANNA):一项随机对照试验性研究。
Front Psychiatry. 2021 Feb 1;12:632660. doi: 10.3389/fpsyt.2021.632660. eCollection 2021.
2
Systemic Delivery of hGhrelin Derivative by Lyophilizate for Dry Powder Inhalation System in Monkeys.冻干物通过干粉吸入系统对猴进行hGhrelin衍生物的全身给药。
Pharmaceutics. 2021 Feb 7;13(2):233. doi: 10.3390/pharmaceutics13020233.
3
Eating Disorders: An Evolutionary Psychoneuroimmunological Approach.饮食失调:一种进化心理神经免疫学方法。
Front Psychol. 2019 Oct 29;10:2200. doi: 10.3389/fpsyg.2019.02200. eCollection 2019.
4
New Treatment Perspectives in Adolescents With Anorexia Nervosa: The Efficacy of Non-invasive Brain-Directed Treatment.青少年神经性厌食症的新治疗前景:非侵入性脑导向治疗的疗效
Front Behav Neurosci. 2018 Jul 20;12:133. doi: 10.3389/fnbeh.2018.00133. eCollection 2018.
5
A dark past, a restrained present, and an apocalyptic future: time perspective, personality, and life satisfaction among anorexia nervosa patients.黑暗的过去、压抑的现在和末日般的未来:神经性厌食症患者的时间观、人格与生活满意度
PeerJ. 2017 Sep 14;5:e3801. doi: 10.7717/peerj.3801. eCollection 2017.
6
Alexithymia in eating disorders: therapeutic implications.饮食失调中的述情障碍:治疗意义。
Psychol Res Behav Manag. 2014 Dec 22;8:1-15. doi: 10.2147/PRBM.S52656. eCollection 2015.

本文引用的文献

1
Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.奥氮平治疗神经性厌食症女性的低体重和强迫观念:一项随机、双盲、安慰剂对照试验。
Am J Psychiatry. 2008 Oct;165(10):1281-8. doi: 10.1176/appi.ajp.2008.07121900. Epub 2008 Jun 16.
2
Evidence-based psychosocial treatments for eating problems and eating disorders.针对饮食问题和饮食失调的循证心理社会治疗方法。
J Clin Child Adolesc Psychol. 2008 Jan;37(1):39-61. doi: 10.1080/15374410701817832.
3
Clinical effectiveness of treatments for anorexia nervosa in adolescents: randomised controlled trial.青少年神经性厌食症治疗的临床疗效:随机对照试验
Br J Psychiatry. 2007 Nov;191:427-35. doi: 10.1192/bjp.bp.107.036764.
4
A randomised controlled treatment trial of two forms of family therapy in adolescent anorexia nervosa: a five-year follow-up.青少年神经性厌食症两种家庭治疗形式的随机对照治疗试验:五年随访
J Child Psychol Psychiatry. 2007 Jun;48(6):552-60. doi: 10.1111/j.1469-7610.2007.01726.x.
5
Olanzapine therapy in anorexia nervosa: psychobiological effects.奥氮平治疗神经性厌食症:心理生物学效应
Int Clin Psychopharmacol. 2007 Jul;22(4):197-204. doi: 10.1097/YIC.0b013e328080ca31.
6
A randomized controlled study of cognitive behavior therapy and behavioral family therapy for anorexia nervosa patients.一项针对神经性厌食症患者的认知行为疗法和行为家庭疗法的随机对照研究。
Eat Disord. 2004 Winter;12(4):303-14. doi: 10.1080/10640260490521389.
7
Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.氟西汀用于神经性厌食症体重恢复后:一项随机对照试验。
JAMA. 2006 Jun 14;295(22):2605-12. doi: 10.1001/jama.295.22.2605.
8
Shared transmission of eating disorders and anxiety disorders.饮食失调与焦虑症的共同传播。
Int J Eat Disord. 2005 Sep;38(2):99-105. doi: 10.1002/eat.20168.
9
Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs.神经性厌食症治疗接受度和完成率的预测因素:对未来研究设计的启示
Arch Gen Psychiatry. 2005 Jul;62(7):776-81. doi: 10.1001/archpsyc.62.7.776.
10
A comparison of short- and long-term family therapy for adolescent anorexia nervosa.青少年神经性厌食症短期与长期家庭治疗的比较
J Am Acad Child Adolesc Psychiatry. 2005 Jul;44(7):632-9. doi: 10.1097/01.chi.0000161647.82775.0a.

目前针对神经性厌食症的治疗:疗效、安全性和依从性。

Current treatment for anorexia nervosa: efficacy, safety, and adherence.

机构信息

Department of Psychology, Florida State University, Tallahassee, FL, USA.

出版信息

Psychol Res Behav Manag. 2010;3:91-108. doi: 10.2147/PRBM.S13814. Epub 2010 Oct 19.

DOI:10.2147/PRBM.S13814
PMID:22110333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3218763/
Abstract

Anorexia nervosa (AN) is a serious psychiatric illness associated with significant medical and psychiatric morbidity, psychosocial impairment, increased risk of death, and chronicity. Given the severity of the disorder, the establishment of safe and effective treatments is necessary. Several treatments have been tried in AN, but few favorable results have emerged. This paper reviews randomized controlled trials in AN, and provides a synthesis of existing data regarding the efficacy, safety, and adherence associated with pharmacologic and psychological interventions. Randomized controlled trials for the treatment of AN published in peer-reviewed journals were identified by electronic and manual searches. Overall, pharmacotherapy has limited benefits in the treatment of AN, with some promising preliminary findings associated with olanzapine, an antipsychotic agent. No single psychological intervention has demonstrated clear superiority in treating adults with AN. In adolescents with AN, the evidence base is strongest for the use of family therapy over alternative individual psychotherapies. Results highlight challenges in both treating individuals with AN and in studying the effects of those treatments, and further emphasize the importance of continued efforts to develop novel interventions. Treatment trials currently underway and areas for future research are discussed.

摘要

神经性厌食症(AN)是一种严重的精神疾病,与显著的医疗和精神发病率、心理社会障碍、死亡风险增加和慢性化有关。鉴于该疾病的严重性,有必要建立安全有效的治疗方法。已经尝试了几种治疗 AN 的方法,但很少有有利的结果出现。本文综述了 AN 的随机对照试验,并综合了关于药物和心理干预相关疗效、安全性和依从性的现有数据。通过电子和手动搜索,确定了在同行评议期刊上发表的治疗 AN 的随机对照试验。总的来说,药物治疗在治疗 AN 方面的益处有限,一些有希望的初步发现与奥氮平(一种抗精神病药物)有关。没有单一的心理干预措施在治疗成人 AN 方面表现出明显的优势。对于患有 AN 的青少年,家庭治疗比其他个体心理治疗更有优势,这方面的证据最强。结果强调了治疗 AN 个体和研究这些治疗效果所面临的挑战,并进一步强调了继续努力开发新干预措施的重要性。目前正在进行的治疗试验和未来研究的领域进行了讨论。